- Hemodialysis and peritoneal dialysis are critical treatment modalities for patients with end-stage renal disease (ESRD), enabling effective removal of waste, toxins, and excess fluids from the blood when kidney function is impaired. These methods are widely used in chronic kidney disease management, both in clinical settings and at home
- The demand for hemodialysis and peritoneal dialysis is significantly driven by the rising prevalence of chronic kidney disease and ESRD, growing preference for home-based dialysis solutions, supportive reimbursement policies, and technological advancements such as portable dialysis machines and improved biocompatible materials
- North America is expected to dominate the hemodialysis and peritoneal dialysis market with a share of 44.5%, with a share of 38.75%, due to a strong network of dialysis centers, advanced healthcare infrastructure, and high awareness regarding kidney disease management
- Asia-Pacific is expected to be the fastest growing region in the hemodialysis and peritoneal dialysis market during the forecast period due to a large aging population, increasing incidence of chronic kidney disease (CKD), and improving healthcare access
- Hemodialysis machines segment is expected to dominate the market with a market share of 83.21% due to high prevalence of end-stage renal disease (ESRD), technological advancements such as portable and home-use machines, widespread availability in healthcare facilities, and strong preference among patients and healthcare providers
